Search results
Results from the WOW.Com Content Network
A total of four ASCO guidelines on medical treatment of patients with metastatic breast cancer (MBC) were found. The Expert Panel was aware of three rapid updates published in 2022; 31 , 32 , 34 however, since this resource-stratified guideline development started before those publications, the recommendations in this guideline do not ...
Treatment for advanced breast cancer can often shrink the cancer or slow its growth (sometimes for many years), but after a time, it tends to stop working. Further treatment options at this point depend on several factors, including previous treatments, where the cancer is located, a woman's menopause status, general health, desire to continue ...
Modern treatments continue to help people with metastatic breast cancer live longer. However, prognosis varies greatly from person to person. About one-third of women diagnosed with metastatic breast cancer in the U.S. live at least 5 years after diagnosis [].
Most metastatic breast cancer is recurrent cancer, meaning it’s cancer that came back after treatment and is affecting tissue and organs located far from the original breast cancer tumor. That said, about 6% of women and people AFAB who receive a breast cancer diagnosis already have metastatic breast cancer.
Metastatic breast cancer treatments under study This is a promising time in metastatic breast cancer research. Many emerging treatments for metastatic breast cancer that could potentially benefit you are under study in clinical trials. Treatment is constantly improving and many clinical trials are underway.